blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1919900

EP1919900 - BICYCLIC HETEROCYCLES MEDICAMENTS COMPRISING SAID COMPOUNDS USE AND METHOD FOR PRODUCTION THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  27.07.2012
Database last updated on 13.09.2024
Most recent event   Tooltip27.07.2012Application deemed to be withdrawnpublished on 29.08.2012  [2012/35]
Applicant(s)For all designated states
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Binger Str. 173
55216 Ingelheim / DE
For:DE 
Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Strasse 173
55216 Ingelheim / DE
[N/P]
Former [2008/20]For all designated states
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Binger Str. 173
D-55216 Ingelheim / DE
For:DE 
Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Strasse 173
55216 Ingelheim / DE
Inventor(s)01 / HIMMELSBACH, Frank
Ahornweg 16
88441 Mittelbiberach / DE
02 / JUNG, Birgit
Schlossaecker 9
88471 Laupheim / DE
 [2008/20]
Representative(s)Hammann, Heinz
Boehringer Ingelheim Pharma GmbH
CD-Patents
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[N/P]
Former [2008/20]Hammann, Heinz
Boehringer Ingelheim Pharma GmbH, CD-Patents, Binger Strasse 173
55216 Ingelheim am Rhein / DE
Application number, filing date06778135.103.08.2006
[2008/20]
WO2006EP65000
Priority number, dateEP2005010767922.08.2005         Original published format: EP 05107679
[2008/20]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report
No.:WO2007023073
Date:01.03.2007
Language:DE
[2007/09]
Type: A2 Application without search report 
No.:EP1919900
Date:14.05.2008
Language:DE
The application published by WIPO in one of the EPO official languages on 01.03.2007 takes the place of the publication of the European patent application.
[2008/20]
Search report(s)International search report - published on:EP18.05.2007
ClassificationIPC:C07D401/12, C07D403/12, C07D239/94, A61K31/517
[2008/20]
CPC:
C07D401/12 (EP,US); A61P1/00 (EP); A61P1/16 (EP);
A61P11/00 (EP); A61P29/00 (EP); A61P35/00 (EP);
A61P43/00 (EP); C07D239/94 (EP,US); C07D403/12 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/20]
TitleGerman:BICYCLISCHE HETEROCYCLEN, DIESE VERBINDUNGEN ENTHALTENDE ARZNEIMITTEL, DEREN VERWENDUNG UND VERFAHREN ZU IHRER HERSTELLUNG[2008/20]
English:BICYCLIC HETEROCYCLES MEDICAMENTS COMPRISING SAID COMPOUNDS USE AND METHOD FOR PRODUCTION THEREOF[2008/20]
French:HETEROCYCLES BICYCLIQUES, PRODUITS PHARMACEUTIQUES CONTENANT CES COMPOSES, LEUR UTILISATION ET PROCEDE POUR LES PREPARER[2008/20]
Entry into regional phase25.03.2008National basic fee paid 
25.03.2008Designation fee(s) paid 
25.03.2008Examination fee paid 
Examination procedure25.03.2008Examination requested  [2008/20]
01.03.2012Application deemed to be withdrawn, date of legal effect  [2012/35]
10.04.2012Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2012/35]
Fees paidRenewal fee
01.09.2008Renewal fee patent year 03
31.08.2009Renewal fee patent year 04
31.08.2010Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.08.201106   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DY]WO03082290  (BOEHRINGER INGELHEIM PHARMA [DE], et al) [DY] 1-11 * Beispiele (32), (33), (57), (81), (111), (128), (168) * * claim - *;
 [Y]WO03082831  (ASTRAZENECA AB [SE], et al) [Y] 1-11 * abstract *;
 [Y]WO2005026151  (ASTRAZENECA AB [SE], et al) [Y] 1-11 * page 4, line 29 - page 5, line 20; examples 1,2,5,6,15,17,20,30-32; claims 1,38-43 *;
 [Y]WO2005012290  (ASTRAZENECA AB [SE], et al) [Y] 1-11 * claim - *;
 [A]DE10042058  (BOEHRINGER INGELHEIM PHARMA [DE]) [A] 1,7-11 * claims 1,8-12 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.